Skip to content
← Full study record

NCT02765854 · MORE INFO

Limitations, agreements, and source contact

Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized With NFKB2 Rearrangement · Source last updated 2025-06-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
lbernalm@wakehealth.edu
organization
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
phone
336-716-9253
title
Leon Bernal-Mizrachi, MD
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
lbernalm@wakehealth.edu
organization
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
phone
336-716-9253
title
Leon Bernal-Mizrachi, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice